PDK1 inhibitors are small molecules designed to specifically inhibit the activity of PDK1. These inhibitors can be classified into several types based on their mechanism of action. Some inhibitors target the ATP-binding site of PDK1, while others may interact with allosteric sites. Examples include compounds like OSU-03012 and BX-912, which have shown varying degrees of efficacy in preclinical studies.
